Annual Working Capital
$412.61 M
+$62.05 M+17.70%
December 31, 2023
Summary
- As of February 7, 2025, PCRX annual working capital is $412.61 million, with the most recent change of +$62.05 million (+17.70%) on December 31, 2023.
- During the last 3 years, PCRX annual working capital has risen by +$14.32 million (+3.59%).
- PCRX annual working capital is now -1.13% below its all-time high of $417.31 million, reached on December 31, 2018.
Performance
PCRX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$383.57 M
-$155.96 M-28.91%
September 30, 2024
Summary
- As of February 7, 2025, PCRX quarterly working capital is $383.57 million, with the most recent change of -$155.96 million (-28.91%) on September 30, 2024.
- Over the past year, PCRX quarterly working capital has increased by +$29.97 million (+8.48%).
- PCRX quarterly working capital is now -35.70% below its all-time high of $596.56 million, reached on September 30, 2021.
Performance
PCRX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
PCRX Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +17.7% | +8.5% |
| 3 y3 years | +3.6% | +6.0% |
| 5 y5 years | -1.1% | +6.0% |
PCRX Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +19.6% | -28.9% | +38.3% |
| 5 y | 5-year | at high | +37.1% | -35.7% | +38.3% |
| alltime | all time | -1.1% | +2816.0% | -35.7% | +1759.8% |
Pacira BioSciences Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $383.57 M(-28.9%) |
| Jun 2024 | - | $539.52 M(+20.0%) |
| Mar 2024 | - | $449.67 M(+9.0%) |
| Dec 2023 | $412.61 M(+17.7%) | $412.61 M(+16.7%) |
| Sep 2023 | - | $353.59 M(+10.4%) |
| Jun 2023 | - | $320.41 M(+15.5%) |
| Mar 2023 | - | $277.42 M(-20.9%) |
| Dec 2022 | $350.56 M(+1.6%) | $350.56 M(-12.8%) |
| Sep 2022 | - | $401.88 M(+2.3%) |
| Jun 2022 | - | $393.03 M(+8.6%) |
| Mar 2022 | - | $361.94 M(+4.9%) |
| Dec 2021 | $344.93 M(-13.4%) | $344.93 M(-42.2%) |
| Sep 2021 | - | $596.56 M(+5.8%) |
| Jun 2021 | - | $563.89 M(+15.5%) |
| Mar 2021 | - | $488.16 M(+22.6%) |
| Dec 2020 | $398.30 M(+32.4%) | $398.30 M(-30.4%) |
| Sep 2020 | - | $572.25 M(+48.5%) |
| Jun 2020 | - | $385.24 M(+9.7%) |
| Mar 2020 | - | $351.28 M(+16.7%) |
| Dec 2019 | $300.88 M(-27.9%) | $300.88 M(+6.3%) |
| Sep 2019 | - | $283.01 M(-9.2%) |
| Jun 2019 | - | $311.61 M(-30.7%) |
| Mar 2019 | - | $449.68 M(+7.8%) |
| Dec 2018 | $417.31 M(+24.6%) | $417.31 M(-0.1%) |
| Sep 2018 | - | $417.53 M(+3.9%) |
| Jun 2018 | - | $402.03 M(+8.5%) |
| Mar 2018 | - | $370.37 M(+10.6%) |
| Dec 2017 | $334.89 M | $334.89 M(+6.8%) |
| Sep 2017 | - | $313.50 M(-20.3%) |
| Jun 2017 | - | $393.48 M(-2.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2017 | - | $402.32 M(+102.9%) |
| Dec 2016 | $198.25 M(+92.9%) | $198.25 M(+123.7%) |
| Sep 2016 | - | $88.61 M(-17.6%) |
| Jun 2016 | - | $107.55 M(+4.9%) |
| Mar 2016 | - | $102.49 M(-0.3%) |
| Dec 2015 | $102.79 M(+38.4%) | $102.79 M(+17.2%) |
| Sep 2015 | - | $87.69 M(+4.2%) |
| Jun 2015 | - | $84.15 M(+1.0%) |
| Mar 2015 | - | $83.30 M(+12.2%) |
| Dec 2014 | $74.25 M(-588.7%) | $74.25 M(+16.0%) |
| Sep 2014 | - | $64.02 M(-19.4%) |
| Jun 2014 | - | $79.40 M(-443.6%) |
| Mar 2014 | - | -$23.11 M(+52.1%) |
| Dec 2013 | -$15.19 M(-132.5%) | -$15.19 M(+187.3%) |
| Sep 2013 | - | -$5.29 M(-105.0%) |
| Jun 2013 | - | $105.66 M(-9.1%) |
| Mar 2013 | - | $116.29 M(+148.7%) |
| Dec 2012 | $46.77 M(-7.8%) | $46.77 M(-28.4%) |
| Sep 2012 | - | $65.30 M(-23.0%) |
| Jun 2012 | - | $84.84 M(+96.8%) |
| Mar 2012 | - | $43.11 M(-15.0%) |
| Dec 2011 | $50.74 M(+244.4%) | $50.74 M(+98.4%) |
| Sep 2011 | - | $25.57 M(-29.2%) |
| Jun 2011 | - | $36.13 M(-18.6%) |
| Mar 2011 | - | $44.36 M(+201.1%) |
| Dec 2010 | $14.73 M(-888.7%) | $14.73 M(+123.7%) |
| Sep 2010 | - | $6.58 M(+37.5%) |
| Jun 2010 | - | $4.79 M(-356.4%) |
| Dec 2009 | -$1.87 M(-179.8%) | -$1.87 M |
| Dec 2008 | $2.34 M | - |
FAQ
- What is Pacira BioSciences annual working capital?
- What is the all time high annual working capital for Pacira BioSciences?
- What is Pacira BioSciences annual working capital year-on-year change?
- What is Pacira BioSciences quarterly working capital?
- What is the all time high quarterly working capital for Pacira BioSciences?
- What is Pacira BioSciences quarterly working capital year-on-year change?
What is Pacira BioSciences annual working capital?
The current annual working capital of PCRX is $412.61 M
What is the all time high annual working capital for Pacira BioSciences?
Pacira BioSciences all-time high annual working capital is $417.31 M
What is Pacira BioSciences annual working capital year-on-year change?
Over the past year, PCRX annual working capital has changed by +$62.05 M (+17.70%)
What is Pacira BioSciences quarterly working capital?
The current quarterly working capital of PCRX is $383.57 M
What is the all time high quarterly working capital for Pacira BioSciences?
Pacira BioSciences all-time high quarterly working capital is $596.56 M
What is Pacira BioSciences quarterly working capital year-on-year change?
Over the past year, PCRX quarterly working capital has changed by +$29.97 M (+8.48%)